Alan Tin‐Lun Lam

Pegylated Recombinant Human Arginase (rhArg-peg5,000mw) Inhibits the <i>In vitro</i> and <i>In vivo</i> Proliferation of Human Hepatocellular Carcinoma through Arginine Depletion

Paul Cheng, Alan Tin‐Lun Lam, Wai-Man Lam et al. · Cancer Research · 2007 · 277 citations · Full text

Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis

Alan Tin‐Lun Lam, Gabriel Wong, Ho‐Yin Chow et al. · Pigment Cell & Melanoma Research · 2010 · 100 citations

Apoptosis, Cell Death, Cell Proliferation +21

Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)

S. M. Tsui, Wai-Man Lam, Alan Tin‐Lun Lam et al. · Cancer Cell International · 2009 · 72 citations · Full text

Biodegradable ECM-coated PCL microcarriers support scalable human early MSC expansion and in vivo bone formation

Asha Shekaran, Alan Tin‐Lun Lam, Eileen Sim et al. · Cytotherapy · 2016 · 66 citations

Regenerative Medicine, Tissue Engineering, Vivo Bone Formation +11

Biodegradable poly-ε-caprolactone microcarriers for efficient production of human mesenchymal stromal cells and secreted cytokines in batch and fed-batch bioreactors

Alan Tin‐Lun Lam, Jian Li, Jessica Pei-Wen Toh et al. · Cytotherapy · 2016 · 64 citations

Tissue Engineering, Regenerative Medicine, Cell-based Drug Delivery +12